FDA Drugs recall ·
Metoclopramide Tablets, USP 10 mg, 100-count bottle, Rx only… recall
- Recall number
- D-0473-2025
- Date
- (initiated May 23, 2025)
- Company / brand
- Teva Pharmaceuticals USA, Inc
400 Interpace Pkwy Bldg A, Parsippany, NJ, United States - Category
- Drugs › Class II
- Classification
- Class II
- Status
- Ongoing
- Units affected
- 36612 cartons
- Initiated by
- Voluntary: Firm initiated
Read the official FDA notice ↗
Product
Metoclopramide Tablets, USP 10 mg, 100-count bottle, Rx only, Manufactured in Croatia by Pliva Hrvatska, d.o.o., Zageb, Croatia, Manufactured for Teva Pharmaceuticals, Parsippany, NJ 07054, NDC 0093-2203-01.
Why was it recalled?
Presence of foreign tablets/capsules.
What should you do?
FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.
Product codes & lot numbers
Lot#: 5420094, Exp 09/30/2027
Distribution
USA Nationwide
What does Class II mean?
Class II means use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious harm is remote.
Source: FDA (drugs), recall D-0473-2025. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.